BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 15741525)

  • 1. Subclinical thyroid disease and cardiovascular disease.
    Caraccio N; Dardano A; Monzani F
    JAMA; 2005 Mar; 293(9):1059-60; author reply 1060. PubMed ID: 15741525
    [No Abstract]   [Full Text] [Related]  

  • 2. [Subclinical hypothyroidism and arteriosclerosis].
    Földes J; Bános C; Winkler G
    Orv Hetil; 2004 Aug; 145(31):1601-7. PubMed ID: 15384857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum lipid levels in relation to serum thyroid-stimulating hormone and the effect of thyroxine treatment on serum lipid levels in subjects with subclinical hypothyroidism: the Tromsø Study.
    Iqbal A; Jorde R; Figenschau Y
    J Intern Med; 2006 Jul; 260(1):53-61. PubMed ID: 16789979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study).
    Meier C; Staub JJ; Roth CB; Guglielmetti M; Kunz M; Miserez AR; Drewe J; Huber P; Herzog R; Müller B
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4860-6. PubMed ID: 11600554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-density lipoprotein cholesterol in subclinical hypothyroidism.
    Vierhapper H; Nardi A; Grösser P; Raber W; Gessl A
    Thyroid; 2000 Nov; 10(11):981-4. PubMed ID: 11128726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired action of thyroid hormone associated with smoking in women with hypothyroidism.
    Müller B; Zulewski H; Huber P; Ratcliffe JG; Staub JJ
    N Engl J Med; 1995 Oct; 333(15):964-9. PubMed ID: 7666915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homocysteine: a risk factor for cardiovascular disease in subclinical hypothyroidism?
    Deicher R; Vierhapper H
    Thyroid; 2002 Aug; 12(8):733-6. PubMed ID: 12225643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex steroids, lipids, and lipoprotein cholesterols in women with subclinical and overt hypothyroidism before and after L-thyroxine therapy.
    Paoli M; Bellabarba G; Velazquez E; Mendoza S; Molina C; Wang P; Glueck CJ
    Clin Chim Acta; 1998 Jul; 275(1):81-91. PubMed ID: 9706846
    [No Abstract]   [Full Text] [Related]  

  • 9. Age and gender substantially influence the relationship between thyroid status and the lipoprotein profile: results from a large cross-sectional study.
    Tognini S; Polini A; Pasqualetti G; Ursino S; Caraccio N; Ferdeghini M; Monzani F
    Thyroid; 2012 Nov; 22(11):1096-103. PubMed ID: 23050788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in lipoprotein(a) levels in overt and subclinical hypothyroidism before and during treatment.
    Tzotzas T; Krassas GE; Konstantinidis T; Bougoulia M
    Thyroid; 2000 Sep; 10(9):803-8. PubMed ID: 11041458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypothyroidism: etiology, diagnosis, and management.
    Almandoz JP; Gharib H
    Med Clin North Am; 2012 Mar; 96(2):203-21. PubMed ID: 22443971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in plasma low-density lipoprotein (LDL)- and high-density lipoprotein cholesterol in hypo- and hyperthyroid patients are related to changes in free thyroxine, not to polymorphisms in LDL receptor or cholesterol ester transfer protein genes.
    Diekman MJ; Anghelescu N; Endert E; Bakker O; Wiersinga WM
    J Clin Endocrinol Metab; 2000 May; 85(5):1857-62. PubMed ID: 10843165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How selective are the new guidelines for treatment of subclinical hypothyroidism for patients with thyrotropin levels at or below 10 mIU/L?
    Rosario PW; Calsolari MR
    Thyroid; 2013 May; 23(5):562-5. PubMed ID: 23627903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein alterations, hepatic lipase activity, and insulin sensitivity in subclinical hypothyroidism: response to L-T(4) treatment.
    Brenta G; Berg G; Arias P; Zago V; Schnitman M; Muzzio ML; Sinay I; Schreier L
    Thyroid; 2007 May; 17(5):453-60. PubMed ID: 17542675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and correction of hypothyroidism in a large cohort of patients referred for dyslipidemia.
    Diekman T; Lansberg PJ; Kastelein JJ; Wiersinga WM
    Arch Intern Med; 1995 Jul; 155(14):1490-5. PubMed ID: 7605150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of central hypothyroidism.
    Beck-Peccoz P
    Clin Endocrinol (Oxf); 2011 Jun; 74(6):671-2. PubMed ID: 21521306
    [No Abstract]   [Full Text] [Related]  

  • 17. Thyroid-Stimulating Hormone in the Evaluation of Subclinical Hypothyroidism.
    Papaleontiou M; Cappola AR
    JAMA; 2016 Oct; 316(15):1592-1593. PubMed ID: 27755618
    [No Abstract]   [Full Text] [Related]  

  • 18. Treating hypothyroidism. Threshold of thyroid stimulating hormone should be higher before treatment is started.
    Cassar J
    BMJ; 1997 Aug; 315(7106):491. PubMed ID: 9284690
    [No Abstract]   [Full Text] [Related]  

  • 19. Thyroid function tests and hypothyroidism. Reducing concentrations further would be harmful.
    Crilly M
    BMJ; 2003 May; 326(7398):1086; author reply 1087. PubMed ID: 12750219
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypothyroxinemia in the preterm infant: the benefits and risks of thyroxine treatment.
    Rapaport R; Rose SR; Freemark M
    J Pediatr; 2001 Aug; 139(2):182-8. PubMed ID: 11487741
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.